This inventor holds 1 USPTO granted patent. Top assignee: Suzhou Ark Biopharmaceutical Co., Ltd.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: **Innovator Spotlight: Teng Feng**
Introduction
Teng Feng is a notable inventor based in Suzhou, China, recognized for his contributions to the field of biopharmaceuticals. With one patent to his name, he reflects the dynamic spirit of innovation that drives advancements in healthcare and medicine.
Latest Patents
Teng Feng holds a patent for a Dihydroisoquinoline compound, which is characterized by a specific general formula. This groundbreaking compound is designed to prevent or treat hepatitis B virus infection, showcasing his commitment to health solutions that can impact many lives.
Career Highlights
Currently, Teng Feng is employed at Suzhou Ark Biopharmaceutical Co., Ltd. Through his role in the company, he engages in research and development that underscores the importance of innovative approaches in treating viral infections. His work is crucial in paving the way for safer and more effective therapeutic options.
Collaborations
Teng collaborates with skilled colleagues including Cheng Peng and Qing Xu, both of whom contribute diverse expertise to their projects. Their teamwork enhances the innovative environment at Suzhou Ark Biopharmaceutical, leading to impactful discoveries in the field.
Conclusion
Teng Feng exemplifies the passion and dedication of inventors contributing to the biopharmaceutical industry. His patent on the Dihydroisoquinoline compound is a testament to his innovative spirit and commitment to improving healthcare outcomes, marking him as a key figure in the fight against hepatitis B.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile